In addition, prostate cancer cell-derived exosomes can promote osteoclast differentiation without the assistance of RANKL, suggesting that prostate cancer cell-derived exosomes can activate non-RANKL-dependent pathways that promote osteoclast differentiation. This evidence concerns the gene TNFSF11 and prostate cancer.